Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high22.500 18/03/16
52 week low15.000 07/03/16
52 week change 2.750 (17.19%)
4 week volume2,433,725 30/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

TRX says DermaPure added to Federal Supply Schedule

Tissue Regenix Group has been included on the US Department of Veteran Affairs (VA) Federal Supply Schedule (FSS) vi...

DermaPure? added to the Federal Supply Schedule

Statement regarding a contract entered into/awarded/signed

Tissue Regenix appoints Paul Devlin as group FD

Tissue Regenix Group announces the appointment of Paul Devlin as Group Finance Director and Company Secretary with...

Directorate Change

Notification of any change to a company’s board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director

Hardman Research: a/c change: Not simply 11/12ths

TR1- NOTIFICATION OF MAJOR INTEREST IN SHARES

Notification of major interests in shares

TRX says DermaPure wins GPO agreement

Tissue Regenix Group announces that Tissue Regenix Wound Care Inc has secured a Group Purchasing Organisation (GPO...

DermaPure secures GPO agreement with Premier, Inc.

Statement regarding a contract entered into/awarded/signed

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Equity Research (TRX)

edison investment research
Tissue Regenix Group Plc
03/02/2017
Edison Investment Research is terminating coverage on Tissue Regenix Group (TRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should...
edison investment research
Tissue Regenix Group Plc
19/10/2016
Tissue Regenix’s interim results are in line with our expectations and demonstrate the progress the company is making to achieve various milestones in each of its divisions. In particular, its Wound...
edison investment research
Tissue Regenix Group Plc
28/07/2016
Tissue Regenix’s (TRX) investment story is built on dCELL, a versatile regenerative medical technology, and its potential across the subsectors: wound care, orthopaedics and cardiac implants....

Latest discussion posts More

  • Re: RNS

    Still under the radar I guess, CL. Interesting to see what happens when the herd gets a whiff !! TP
    5-Feb-2017
    theprior
  • Re: RNS

    Thought there would have been a greater impact on the SP. Great start tailed off. CL
    2-Feb-2017
    Chicken Lips
  • RNS

    New marketing opportunity for Dermapure tm Revenue creating. Profit enhancing. Another duck... TP
    2-Feb-2017
    theprior

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..
LLOYDS GRP.31%
BP23%
TESCO23%
SIRIUS MINERALS21%
CENTRICA18%

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX